Celularity Inc.

CELU

NASDAQ

Healthcare

Biotechnology

Florham Park, NJ, US120 employeescelularity.com

$1.34

+0.03(2.29%)

Mkt Cap $32M

$1.11

$4.15

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Product (63%), License Royalty And Other (23.3%), Service (13.7%).

8-K

Celularity Inc. entered into an Asset Purchase and Exclusive License Agreement with NexGel, Inc. on March 6, 2026. The Company issued a press release on March 10, 2026 announcing the transaction, with the agreement filed as Exhibit 10.1.

$32M

Market Cap

$37M

Revenue

-$74M

Net Income

Employees120

Fundamentals

How The Business Makes Money

Revenue by Segment

Product63%($48M)

License Royalty And Other23.3%($18M)

Service13.7%($11M)

Activity

What Changed Recently

Management Change

Mar 4, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers . On February 2

Management Change

Jan 20, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers . On January 16

Material Agreement

Mar 9, 2026

. Entry into a Material Definitive Agreement. On March 6, 2026, Celularity Inc., a Delaware corporation (the “Company”), entered into an Asset Purchase and Excl

Peer Companies

Company	Price	Change	Market Cap	P/E
KZRKezar Life Sciences, Inc.	$7.40	+0.20%	$54M	-0.8
ANVSAnnovis Bio, Inc.	$2.27	+7.31%	$45M	-2.1
PYPDPolyPid Ltd.	$4.38	-0.34%	$45M	-2.5
FGENFGEN	$9.07	-1.63%	$37M	—
GBIOGBIO	$5.34	+0.00%	$36M	—
ATNMActinium Pharmaceuticals,...	$0.98	-0.89%	$31M	—
BTAIBioXcel Therapeutics, Inc...	$1.18	-3.69%	$29M	-0.3
BCABBioAtla, Inc.	$0.13	-3.42%	$8M	-0.2

Analyst View

Company Profile

CIK0001752828

ISINUS1511902041

CUSIP151190105

Phone908 768 2170

Address170 Park Avenue, Florham Park, NJ, 07932, US

SEC EDGAR